Navigation Links
Immucor Schedules First Quarter Earnings Release and Conference Call

NORCROSS, Ga., Sept. 28 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its first quarter earnings on Wednesday, October 3, 2007, after the close of regular trading hours, and then host a conference call on Thursday, October 4, 2007 at 8:30 AM (EDT) to review the results. Investors are invited to participate in this conference call, with Dr. Gioacchino De Chirico, President and Chief Executive Officer, Patrick D. Waddy, Chief Financial Officer and Edward L. Gallup, consultant. The call will focus on the results for the first quarter and general business trends. The earnings release will be posted on Immucor's website, as well as any material financial information that may be discussed by Dr. De Chirico, Mr. Waddy or Mr. Gallup during this call that is not contained in the earnings release. Both the earnings release and the additional financial information, if any, will be posted as soon as practicable after the call on the investor news section of Immucor's website. To access this information once posted, go to Immucor's website at and click on "About Us - Press Releases."

To participate in the telephone conference call, dial 1-800-593-0187 and passcode BLUD. Replays of the conference call will be available for one week beginning at 12:00 noon on October 4th by calling 1-888-484-8256. Beginning October 11, 2007, audio of the conference call or a transcript of the audio will be available on the "About Us - Press Releases" page of the Immucor website.

For more information on Immucor, please visit our website at

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.

SOURCE Immucor
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
2. Vaccination Schedules Rates among Canadian Kids Dip Low
3. UP Government Fixes Work Schedules for Provincial Medical Service Doctors
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Infant receives first bloodless liver transplant
6. Oracle Corp. to help build worlds first "Digital Hospital"
7. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
8. First human clone is near
9. First Artificial Heart patient has Major setback
10. FDA approves first pocket-sized EKG machine
11. First head-to-head trials of once weekly Fosamax and Actonel therapies
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: